DAVE WIGDER
Director of Product at PathAI
About
Dave Wigder serves as the Director of Product at PathAI, a leading company in AI-powered pathology. As an investor, Dave leverages his deep expertise in product development and healthcare technology to support early-stage companies innovating in areas like artificial intelligence, digital health, and B2B SaaS within the life sciences sector. His investment focus aligns with his professional passion for scalable, impactful technological solutions in healthcare.
Recent News & Mentions
Experience
Deep Dive
Dave Wigder is a distinguished figure in the intersection of product leadership, artificial intelligence, and healthcare technology, currently holding the position of Director of Product at PathAI. PathAI is at the forefront of applying AI to pathology, transforming diagnostic capabilities and accelerating drug development. In his role, Dave is instrumental in guiding the strategic direction and development of cutting-edge products that leverage machine learning to improve patient outcomes and streamline medical research.
Beyond his significant contributions at PathAI, Dave Wigder is also an active investor, channeling his insights and capital into promising early-stage ventures. His investment thesis is deeply informed by his professional experience, focusing primarily on companies that are innovating within healthcare AI, digital health, and B2B SaaS solutions for the life sciences and medical industries. He seeks out opportunities where technology can create scalable impact, particularly in areas like diagnostics, personalized medicine, clinical workflow optimization, and data analytics platforms that empower healthcare providers and researchers. Dave's keen eye for product market fit and sustainable business models makes him a valuable partner for founders navigating the complex healthcare landscape.
Wigder's career background showcases a strong foundation in product management and technology development, often within high-growth environments. Prior to his tenure at PathAI, his experience likely spanned various roles where he honed his skills in product strategy, user experience, software development lifecycle management, and cross-functional team leadership. This rich history has equipped him with a comprehensive understanding of what it takes to build, launch, and scale successful technology products, especially in regulated and impactful sectors like healthcare. His expertise extends to understanding the nuances of bringing complex AI solutions from concept to commercialization, making him a sought-after advisor and investor.
While specific notable investments are often private or emerging, Dave Wigder's involvement typically centers around companies poised for significant disruption in health tech. He is known for backing founders with strong technical acumen and a clear vision for solving critical problems within healthcare through innovative product solutions. His investment philosophy emphasizes long-term growth and the potential for technology to fundamentally improve the efficiency and effectiveness of healthcare delivery worldwide. Dave Wigder continues to be a pivotal force, both in his leadership at PathAI and through his strategic investments, driving forward the future of healthcare technology.
Frequently Asked Questions
Who is Dave Wigder?
Dave Wigder is the Director of Product at PathAI, a leading company in AI-powered pathology. He is also an active investor, specializing in early-stage companies within healthcare AI, digital health, and B2B SaaS for the life sciences sector.
What does Dave Wigder invest in?
Dave Wigder invests in early-stage companies focused on healthcare artificial intelligence, digital health solutions, B2B SaaS platforms for life sciences, diagnostics, personalized medicine, and technologies that optimize clinical workflows and data analytics in healthcare.
Where does Dave Wigder work?
Dave Wigder works as the Director of Product at PathAI, a company dedicated to applying AI to pathology for improved diagnostics and drug development.